France · Seed startup

Who invested in Brink Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$4.0Mraised across 1 round since 2025, from 1 source

Latest round
Seed, $4.0MApr 2025
Investors
5
See who backed them

The rounds

  1. Apr 2025

Founders and team

From Brink Therapeutics's own website: 1 founder, 2 on the team.

Prof. Andrew GriffithsCo-founder
  • Artificial IntelligenceSenior Scientist
  • Molecular BiologySenior Scientist

Everyone who backed them

Plug and PlayAccelerator1round
Kima VenturesVC firm1round
AGORANOVAccelerator1round
BreegaVC firm1round
KurmaPartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Brink Therapeutics

Who invested in Brink Therapeutics?

Brink Therapeutics's investors include Plug and Play, Kima Ventures, AGORANOV, Breega and KurmaPartners.

How much has Brink Therapeutics raised?

Brink Therapeutics has raised $4.0M across 1 round since 2025.

When did Brink Therapeutics last raise?

Brink Therapeutics's most recent round was a Seed of $4.0M in Apr 2025.

What was Brink Therapeutics's biggest round?

Its most recent round, $4.0M in Apr 2025, is also its largest on record.

Who backed Brink Therapeutics first?

Brink Therapeutics's first round on record, in Apr 2025, was backed by Plug and Play, Kima Ventures and AGORANOV and 2 others.

What stage is Brink Therapeutics at?

Brink Therapeutics's latest named round is a Seed, in Apr 2025.

Where is Brink Therapeutics based?

Brink Therapeutics is based in France.

Companies like Brink Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.